Goserelin 3.6 MG: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Goserelin 3.6 MG

• Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
  NCT06953882 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
  NCT04894188 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 75 Years · Sex: Male · 2 locations
• Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer
  NCT06575257 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Male · 1 location

Common questions

How many recruiting trials involve Goserelin 3.6 MG?

3 recruiting trials across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.